CARDIOPROGRESS
Foundation for the advancement of cardiology

Updated recommendations for adults with congenital heart defects On December 18, updated guidelines for management of adults with congenital heart disease, developed by the American College of Cardiology (ACC) and the American Heart Association (AHA) in conjunction with several other societies, were published in Circulation and the Journal of the American College of Cardiology.

Can Interventional EP Go Outpatient? Is interventional electrophysiology poised for a paradigm shift? The American College of Cardiology and Heart Rhythm Society may think so. In a joint scientific statement, they offer guidance on performing certain procedures, such as cardiac ablation, in facilities that provide same-day surgical care without the need for hospital admission.

World Heart day 2025 World Heart Day is celebrated annually on September 29. Since its inception, the Cardioprogress Foundation has actively collaborated with the World Heart Federation and, to celebrate this occasion, organizes events in various cities across the Russian Federation.

EASD to Feature Major Trial Results, Clinical Guidance The European Association for the Study of Diabetes (EASD) 2025 Annual Meeting will feature major clinical trial results in type 2 diabetes (T2D), type 1 diabetes (T1D), obesity, several new clinical practice guidelines, and much more.

2025 ESC Congress HOT LINE sessions: key clinical studies From August 29 to September 1, 2025, the regular Congress of the European Society of Cardiology was held in Madrid (Spain), combined this year with the World Congress of Cardiology. The main theme of the event was "Global Health: Cardiology Without Borders".
This event brought together leading experts and researchers from different countries and allowed them to discuss new research and achievements in the treatment of cardiovascular diseases.

Cardioprogress Newsletter Dear Colleagues!
The Cardioprogress Foundation resumes publishing a quarterly newsletter dedicated to scientific news in cardiology. If you are interested in specific topics and details of scientific discoveries in the field of cardiology, please write to us. (The e-mail address is indicated on the last page of the newsletter).

Baxdrostat: A “Game Changer” for Hypertension? A new class of antihypertensive agent that blocks the production of aldosterone — a key hormone believed to drive increased blood pressure — has shown impressive results in one of the first pivotal phase 3 trials in patients with resistant or uncontrolled hypertension.

ACC Recommends Vaccination Against Respiratory Illness in Cardiovascular Disease Adults with heart disease should get vaccinated against a range of respiratory viruses, according to new clinical guidance from the American College of Cardiology.

New Type 2 Diabetes Guidance Ties Treatment Choice to Cardio-Renal Risk New guidance on preventing cardiovascular (CV) and renal complications in type 2 diabetes (T2D) emphasizes tailoring therapy to a patient’s individual risk profile.

ACC and AHA guidelines for the treatment of hypertension have been updated The target blood pressure level for adults remains below 130/80 mm Hg, but drug therapy should be initiated sooner, according to new guidelines published by the American Heart Association (AHA) and American College of Cardiology (ACC). Eleven other medical organizations endorsed the new guidelines, which replace those issued in 2017.